囊性纤维化患者的药理避孕方法:临床医生的实用性审查
E Claire Elson1, Taylor Imburgia2, Kevin Lonabaugh3
1Department of Pharmacy, Children's Mercy, 2401 Gillham Road, Kansas City, MO 64108, United States.
概括
由于患有囊性纤维化 (CF) 的人寿命更长,讨论计划生育和避孕非常重要. 本综述涵盖了荷尔蒙避孕方案,强调了CF患者特有的好处和风险.
科学领域:
- 生殖健康 生殖健康
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 囊性纤维化 (CF) 治疗的进步显著改善了CF (PwCF) 患者的寿命和生活质量.
- 由于PwCF人口的增长和老龄化,需要解决长期的健康问题.
- 计划生育,生殖健康和避孕是PwCF及其护理团队日益相关的主题.
研究的目的:
- 审查现有的药理避孕方法.
- 专注于与PwCF相关的这些方法的好处和风险.
- 为CF临床医生提供指导,与PwCF.CF讨论避孕.
主要方法:
- 对药理学避孕选择的文献综述.
- 分析关于避孕药的有效性和安全性的现有数据.
- 考虑影响避孕选择的CF特异性健康因素.
主要成果:
- 讨论各种激素避孕药配方 (例如,联合口服避孕药,仅用孕激素的方法).
- 识别潜在的益处,如激素调节和月经周期管理.
- 强调与PwCF相关的潜在风险或禁忌,包括药物相互作用和特定的健康状况.
结论:
- 避孕是对老龄化PwCF人口的综合护理的重要组成部分.
- 结核病护理团队在启动关于计划生育和生殖健康的讨论方面发挥着至关重要的作用.
- 根据信息选择药理避孕需要仔细考虑个人PwCF健康状况.
相关概念视频
Birth Control Methods
230
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
230
Cystic Fibrosis: Management
154
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
154
Cystic Fibrosis: Pathogenesis
214
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
214
Drugs for Treatment of Constipation-Predominant IBS
157
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
157
Drug Delivery: Miscellaneous Routes
338
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
338
Antiasthma Drugs: Leukotriene Modifiers
276
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
276


